Proteasome inhibitors: closing the garbage can opens up new therapeutic options for patients with B-cell malignancies.
Berenson
James R
JR
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D015448:Leukemia, B-Cell / Q000188:drug therapy* / Q000201:enzymology; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000201:enzymology; D011480:Protease Inhibitors / Q000627:therapeutic use*; D061988:Proteasome Inhibitors
D000970:Antineoplastic Agents; D011480:Protease Inhibitors; D061988:Proteasome Inhibitors